ALGS vs C · rev $3.6M vs P/E 16, rev $85.22B
Aligos Therapeutics Inc (ALGS) versus Citigroup Inc. (C) — a side-by-side from cached financials, not a winner call.
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
Citigroup Inc. (C) is a banks - diversified company listed on US.
Latest reported ALGS revenue for 2024-12-31 was $3.6M. Net income was -$131.2M. Revenue was down 41.7% from 2023-12-31 to 2024-12-31. ALGS currently screens at market cap $44.1M.
Latest reported C revenue for 2025-12-31 was $85.22B. Net income was $14.31B. Revenue was up 5.0% from 2024-12-31 to 2025-12-31. C currently screens at market cap $214.73B and trailing P/E 15.5.
ALGS currently screens at market cap $44.1M. C currently screens at market cap $214.73B and trailing P/E 15.5.
Not investment advice. Open the ALGS and C stock pages for the full models.
Not investment advice.